MDCE Advances Continuously Learning AI Models Within StrainScan Pro for Greater Visual Accuracy Across Agricultural and Retail Environments (OTC PINK:MDCE)

Rhea-AI Summary

Medical Care Technologies (OTC PINK: MDCE) reported further technical progress on its StrainScan Pro AI vision platform, emphasizing continuously learning computer-vision models designed to improve visual accuracy over time in both agricultural and regulated retail environments.

According to the company, StrainScan Pro refines performance as it processes more real-world visual data, enhancing identification of strain and quality characteristics for licensed operators and supporting detection of pests, crop stress, and quality indicators in agricultural settings. The software is optimized for deployment on iPad Air devices, preserving a portable enterprise form factor while the underlying AI models evolve. Medical Care Technologies stated that it develops and commercializes AI vision software, does not handle plant products, and is advancing AI capabilities across high-value verticals while generating revenue through operating subsidiaries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Proprietary Platform Designed to Improve Over Time Through Ongoing Model Training and Real-World Visual Data

MESA, AZ / ACCESS Newswire / August 24, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted continued technical progress within its StrainScan Pro platform, focusing on the advancement of continuously learning AI models that support greater visual accuracy across both agricultural and regulated retail environments.

StrainScan Pro is built on proprietary computer-vision architecture designed to refine performance as it processes additional visual data. This continuous learning approach allows the platform to strengthen its ability to identify relevant visual patterns over time - whether supporting strain and quality verification for licensed operators or assisting with the detection of pests, crop stress, and quality indicators in agricultural settings.

By prioritizing ongoing model training, Medical Care Technologies is focused on delivering a platform that becomes more capable with use rather than remaining static. The software remains optimized for deployment on iPad Air devices, maintaining a portable enterprise form factor while the underlying intelligence continues to evolve.

"Our development philosophy centers on building systems that improve," said Marshall Perkins, CEO of Medical Care Technologies. "StrainScan Pro is not a fixed tool. It is a proprietary platform designed to learn from visual data over time, increasing its value for operators who need consistent and increasingly accurate analysis across field and retail environments."

Medical Care Technologies is a technology company. It develops and commercializes AI vision software and does not cultivate, process, distribute, or sell cannabis or any plant products.

As demand grows for reliable visual intelligence across multi-billion-dollar retail sectors and the multi-trillion-dollar global agriculture market, the ability of a platform to improve through continuous learning represents a meaningful technical advantage. Medical Care Technologies remains focused on advancing this capability within StrainScan Pro.

Investors and industry participants can explore the platform at: https://strainscanpro.com

Medical Care Technologies continues to advance its AI vision capabilities across high-value verticals while generating revenue through its operating subsidiaries.

About Medical Care Technologies Inc. Medical Care Technologies Inc. (OTC Pink: MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://medicalcaretechnologies.com

Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information: Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204 Phone: +1 (480) 645-0750 Email: marshall@medicalcaretechnologies.com Websites: https://medicalcaretechnologies.com | https://strainscanpro.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What did Medical Care Technologies (OTC PINK: MDCE) announce about StrainScan Pro on August 24, 2026?

Medical Care Technologies announced ongoing technical progress in its StrainScan Pro platform, highlighting continuously learning AI models that improve visual accuracy. According to the company, the system refines performance using real-world visual data across agricultural and regulated retail environments, enhancing pattern recognition and analysis over time.

How does StrainScan Pro’s continuously learning AI benefit agricultural and retail users of MDCE’s platform?

StrainScan Pro’s continuously learning AI improves its ability to recognize relevant visual patterns as more images are processed. According to Medical Care Technologies, this supports strain and quality verification for licensed operators and assists with detecting pests, crop stress, and other quality indicators in agricultural settings.

On which devices is MDCE’s StrainScan Pro AI vision software currently optimized to run?

StrainScan Pro is optimized for deployment on iPad Air devices, maintaining a portable enterprise form factor. According to Medical Care Technologies, this hardware focus allows operators to use a mobile, field-ready system while the underlying AI intelligence continues to evolve through ongoing model training.

Does Medical Care Technologies (MDCE) cultivate or sell cannabis as part of the StrainScan Pro offering?

Medical Care Technologies states that it does not cultivate, process, distribute, or sell cannabis or any plant products. According to the company, its business centers on developing and commercializing AI vision software that can support regulated retail and agricultural operators through visual analysis.

What markets is MDCE targeting with its StrainScan Pro AI vision platform?

Medical Care Technologies is targeting multi-billion-dollar retail sectors and the multi-trillion-dollar global agriculture market with StrainScan Pro. According to the company, the platform’s continuous learning capability is positioned as a technical advantage for operators needing reliable visual intelligence and improving analytical accuracy.

How does StrainScan Pro fit into Medical Care Technologies’ broader AI strategy and revenue model?

StrainScan Pro is part of Medical Care Technologies’ focus on AI-powered applications in health, wellness, lifestyle, nutrition, and enterprise imaging. According to the company, it continues to advance AI vision capabilities across high-value verticals while generating revenue through its operating subsidiaries.